BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,811,208 | -9.4% | 2,300,244 | -2.6% | 0.04% | -15.2% |
| Q2 2023 | $95,824,215 | 0.0% | 2,362,530 | 0.0% | 0.05% | 0.0% |
| Q1 2023 | $95,824,215 | -26.3% | 2,362,530 | -7.3% | 0.05% | -32.4% |
| Q4 2022 | $129,942,412 | -99.9% | 2,549,390 | +11.5% | 0.07% | -1.4% |
| Q3 2022 | $123,162,577,000 | -12.2% | 2,286,717 | +4.7% | 0.07% | -5.5% |
| Q2 2022 | $140,255,260,000 | -39.2% | 2,183,641 | -26.6% | 0.07% | -26.3% |
| Q1 2022 | $230,803,858,000 | +0.7% | 2,976,578 | +11.4% | 0.10% | +12.5% |
| Q4 2021 | $229,282,848,000 | +11.7% | 2,671,049 | +4.7% | 0.09% | +3.5% |
| Q3 2021 | $205,220,363,000 | +0.8% | 2,551,540 | +0.9% | 0.08% | -2.3% |
| Q2 2021 | $203,560,433,000 | -1.3% | 2,528,701 | +3.4% | 0.09% | -4.4% |
| Q1 2021 | $206,254,903,000 | +5.4% | 2,445,517 | +0.3% | 0.09% | -1.1% |
| Q4 2020 | $195,657,217,000 | +3.3% | 2,438,400 | +3.5% | 0.09% | -9.8% |
| Q3 2020 | $189,484,559,000 | -5.4% | 2,356,187 | +1.3% | 0.10% | -16.4% |
| Q2 2020 | $200,254,824,000 | -0.2% | 2,325,840 | -5.8% | 0.12% | -15.3% |
| Q1 2020 | $200,563,901,000 | +11.7% | 2,470,303 | +15.0% | 0.14% | +30.9% |
| Q4 2019 | $179,572,948,000 | -7.7% | 2,147,488 | -3.4% | 0.11% | -16.0% |
| Q3 2019 | $194,473,802,000 | +11.3% | 2,223,320 | +4.2% | 0.13% | +4.8% |
| Q2 2019 | $174,688,441,000 | +5.1% | 2,132,948 | +4.3% | 0.12% | +1.6% |
| Q1 2019 | $166,220,733,000 | +28.6% | 2,044,284 | +4.1% | 0.12% | +10.8% |
| Q4 2018 | $129,299,440,000 | -7.8% | 1,964,440 | +8.0% | 0.11% | +6.7% |
| Q3 2018 | $140,181,151,000 | -4.3% | 1,818,409 | -8.3% | 0.10% | -7.1% |
| Q2 2018 | $146,466,808,000 | +2.4% | 1,983,570 | -9.8% | 0.11% | -0.9% |
| Q1 2018 | $142,964,227,000 | +3.2% | 2,198,097 | +2.5% | 0.11% | -3.4% |
| Q4 2017 | $138,587,384,000 | -3.0% | 2,143,988 | -5.8% | 0.12% | -10.0% |
| Q3 2017 | $142,812,287,000 | +4.2% | 2,275,893 | +0.6% | 0.13% | -2.3% |
| Q2 2017 | $137,016,491,000 | +15.0% | 2,263,239 | -1.5% | 0.13% | +9.9% |
| Q1 2017 | $119,099,551,000 | +129795.1% | 2,296,559 | +11.1% | 0.12% | +17.5% |
| Q4 2016 | $91,689,000 | -7.7% | 2,067,858 | -0.9% | 0.10% | -3.7% |
| Q3 2016 | $99,316,000 | +7.5% | 2,086,491 | +2.2% | 0.11% | +2.9% |
| Q2 2016 | $92,346,000 | +30.3% | 2,042,142 | +18.3% | 0.10% | +26.8% |
| Q1 2016 | $70,893,000 | +7.3% | 1,725,743 | -0.3% | 0.08% | +9.3% |
| Q4 2015 | $66,056,000 | +11.5% | 1,731,453 | -4.0% | 0.08% | +15.4% |
| Q3 2015 | $59,229,000 | -58.9% | 1,802,984 | -12.4% | 0.06% | -52.9% |
| Q2 2015 | $143,935,000 | +0.1% | 2,058,272 | -1.9% | 0.14% | -0.7% |
| Q1 2015 | $143,787,000 | -7.0% | 2,099,072 | -0.5% | 0.14% | -5.4% |
| Q4 2014 | $154,598,000 | -11.7% | 2,109,401 | -13.5% | 0.15% | -15.5% |
| Q3 2014 | $174,999,000 | -1.3% | 2,438,345 | -0.6% | 0.17% | -2.8% |
| Q2 2014 | $177,370,000 | -11.1% | 2,453,262 | -9.6% | 0.18% | -16.0% |
| Q1 2014 | $199,625,000 | -22.4% | 2,713,049 | -26.7% | 0.21% | -27.6% |
| Q4 2013 | $257,375,000 | +12.3% | 3,700,551 | +6.0% | 0.29% | +3.9% |
| Q3 2013 | $229,285,000 | -13.4% | 3,490,401 | -8.7% | 0.28% | -17.3% |
| Q2 2013 | $264,852,000 | – | 3,823,494 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |